Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

I once thought that prostate cancer should be the center of my universe, but with everything else going on, now I’m not so ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Prostate cancer is the most common cancer in men, with an estimated one in eight Canadian men expected to be diagnosed in ...

Once prostate cancer has spread, other treatments are required. To check for signs of metastasis in people who have already undergone surgery or radiation but whose prostate-specific antigen (PSA ...

During Movember, Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, ...

When prostate cancer cells burst as a result of menadione treatment, there is no risk of metastasis. This event represents a ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...

Here are the symptoms and early signs of prostate cancer as well as the life expectancy of those with the condition.